JP2006089487A5 - - Google Patents

Download PDF

Info

Publication number: JP2006089487A5
Authority: JP; Japan
Prior art keywords: citrulline; active ingredient; antioxidant; active; therapeutic
Prior art date: 2005-10-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2005290190A

Other languages

English (en)

Japanese (ja)

Other versions

JP4691658B2 (ja

JP2006089487A (ja

Filing date

2005-10-03

Publication date

2006-07-20

2005-10-03 Application filed filed Critical

2005-10-03 Priority to JP2005290190A priority Critical patent/JP4691658B2/ja

2005-10-03 Priority claimed from JP2005290190A external-priority patent/JP4691658B2/ja

2006-04-06 Publication of JP2006089487A publication Critical patent/JP2006089487A/ja

2006-07-20 Publication of JP2006089487A5 publication Critical patent/JP2006089487A5/ja

2011-06-01 Application granted granted Critical

2011-06-01 Publication of JP4691658B2 publication Critical patent/JP4691658B2/ja

2021-02-05 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims 4
RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims 4
239000004480 active ingredient Substances 0.000 claims 4
229960002173 citrulline Drugs 0.000 claims 4
235000013477 citrulline Nutrition 0.000 claims 4
239000003963 antioxidant agent Substances 0.000 claims 2
230000003078 antioxidant effect Effects 0.000 claims 2
230000007018 DNA scission Effects 0.000 claims 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
239000003795 chemical substances by application Substances 0.000 claims 1
239000002537 cosmetic Substances 0.000 claims 1
201000010099 disease Diseases 0.000 claims 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
235000013373 food additive Nutrition 0.000 claims 1
239000002778 food additive Substances 0.000 claims 1
239000003112 inhibitor Substances 0.000 claims 1
229910052760 oxygen Inorganic materials 0.000 claims 1
239000001301 oxygen Substances 0.000 claims 1
230000000069 prophylactic effect Effects 0.000 claims 1
230000001225 therapeutic effect Effects 0.000 claims 1

JP2005290190A 2005-10-03 2005-10-03 抗酸化食品添加物 Expired - Fee Related JP4691658B2 (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP2005290190A JP4691658B2 (ja)	2005-10-03	2005-10-03	抗酸化食品添加物

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2005290190A JP4691658B2 (ja)	2005-10-03	2005-10-03	抗酸化食品添加物

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2001027772A Division JP3843298B2 (ja)	2001-02-05	2001-02-05	シトルリンを含有する活性酸素消去剤

Publications (3)

Publication Number	Publication Date
JP2006089487A JP2006089487A (ja)	2006-04-06
JP2006089487A5 true JP2006089487A5 (fr)	2006-07-20
JP4691658B2 JP4691658B2 (ja)	2011-06-01

Family

ID=36230788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2005290190A Expired - Fee Related JP4691658B2 (ja)	2005-10-03	2005-10-03	抗酸化食品添加物

Country Status (1)

Country	Link
JP (1)	JP4691658B2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPWO2008105384A1 (ja) *	2007-02-26	2010-06-03	協和発酵バイオ株式会社	シトルリン含有錠剤
JP5288788B2 (ja) *	2007-12-28	2013-09-11	三菱鉛筆株式会社	水性インキ組成物
JP2014045683A (ja) *	2012-08-30	2014-03-17	Fuji Oil Co Ltd	食用油脂及びそれを含有する食品並びにその製造方法
JP2014118405A (ja) *	2012-12-19	2014-06-30	Kose Corp	Ｄｎａ損傷抑制剤
JP2014129267A (ja) *	2012-12-28	2014-07-10	Kose Corp	Ｄｎａ損傷抑制剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3561920D1 (en) *	1984-09-12	1988-04-28	Firmenich & Cie	Process for improving or modifying the taste and aroma of citrus fruit compositions
DE4341000A1 (de) *	1993-12-02	1995-06-08	Beiersdorf Ag	Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
JPH09241637A (ja) *	1996-03-14	1997-09-16	Chugai Pharmaceut Co Ltd	活性酸素ラジカル除去用組成物およびその方法
US6028107A (en) *	1997-02-27	2000-02-22	Waugh; William Howard	Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection

2005
- 2005-10-03 JP JP2005290190A patent/JP4691658B2/ja not_active Expired - Fee Related

Similar Documents

Publication	Publication Date	Title
AU2007299727A8 (en)	2009-04-09	Self preserved aqueous pharmaceutical compositions
AP2405A (en)	2012-05-02	Cannabinoid active pharmaceutical ingredient for improved dosage forms.
ZA200809864B (en)	2010-03-31	Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
WO2006096439A3 (fr)	2007-02-08	Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
WO2006091529A3 (fr)	2007-02-08	Preparation pharmaceutique solide
WO2009137391A3 (fr)	2009-12-30	Composés de benzène sulfonamide thiazole et oxazole
EP2607348A3 (fr)	2013-10-16	Agent inhibiteur de l'inhibiteur de l'activateur du plasminogène 1
IL198411A0 (en)	2010-02-17	Haloalkylsulfonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide
WO2008148074A3 (fr)	2009-03-19	Inhibiteurs de mtor et methodes de traitement mettant en œuvre ces inhibiteurs
WO2007038459A3 (fr)	2007-07-12	Composes de carboxyamine et leurs methodes d'utilisation
NO20080220L (no)	2008-04-21	Formuleringer med hoy medikament belastning og doseringsformer
WO2010021607A3 (fr)	2010-06-03	Préparation pharmaceutique
IL185197A0 (en)	2008-01-06	Ophthalmological pharmaceutical compositions
IL191758A0 (en)	2008-12-29	Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
DK1932522T3 (da)	2012-07-02	Terapeutisk middel mod leversygdom indeholdende 2-amino-1,3-propandiolderivat som aktiv bestanddel
WO2007009720A3 (fr)	2007-04-12	Promedicaments de composes de pyrazoline, fabrication et utilisation comme medicaments
WO2007009721A3 (fr)	2007-03-29	Derives de pyrazoline substitues indoline, preparation et utilisation comme medicaments
WO2009106599A3 (fr)	2009-12-03	Pipéridines substituées en tant que composés thérapeutiques
WO2006056696A3 (fr)	2006-08-31	2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
JP2006089487A5 (fr)	2006-07-20
DK1666473T3 (da)	2013-03-25	Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
ITRM20050179A1 (it)	2006-10-14	Composizione impiegabile per il trattamento delle patologie paradontali.
WO2007009686A3 (fr)	2007-03-08	Composes de pyrazoline substituee, preparation et utilisation de ceux-ci comme medicaments
IL187419A0 (en)	2008-02-09	Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
WO2007066200A3 (fr)	2007-09-07	Inhibiteurs innovants des cysteine-proteases, leurs compositions pharmaceutiques et leurs applications therapeutiques